The Lancet Infectious Diseases in conversation with – Details, episodes & analysis
Podcast details
Technical and general information from the podcast's RSS feed.
The Lancet Infectious Diseases in conversation with
The Lancet Group
Frequency: 1 episode/71d. Total Eps: 21
Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.
Recent rankings
Latest chart positions across Apple Podcasts and Spotify rankings.
Apple Podcasts
🇬🇧 Great Britain - medicine
19/05/2026#76🇬🇧 Great Britain - medicine
17/05/2026#84🇬🇧 Great Britain - medicine
03/05/2026#83🇬🇧 Great Britain - medicine
20/04/2026#92🇫🇷 France - medicine
09/09/2025#76🇫🇷 France - medicine
08/09/2025#56🇩🇪 Germany - medicine
29/08/2025#98🇫🇷 France - medicine
30/07/2025#100🇫🇷 France - medicine
29/07/2025#76🇫🇷 France - medicine
28/07/2025#50
Spotify
No recent rankings available
Shared links between episodes and podcasts
Links found in episode descriptions and other podcasts that share them.
See all- https://facebook.com/thelancetmedicaljournal
4384 shares
- https://www.instagram.com/thelancetgroup
4384 shares
RSS feed quality and score
Technical evaluation of the podcast's RSS feed quality and structure.
See allScore global : 48%
Publication history
Monthly episode publishing history over the past years.
Prasad Kulkarni on dengue monoclonal antibodies
vendredi 23 février 2024 • Duration 18:53
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.
Read the full article:
https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Oriol Mitjà on treatment of early syphilis in adults
lundi 8 janvier 2024 • Duration 15:25
Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.
Read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Josep Llibre on preventing SARS-CoV-2 transmission at concerts
jeudi 27 mai 2021 • Duration 08:10
Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain.
Read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Yap Boum on COVID-19 testing in low resource settings
jeudi 25 mars 2021 • Duration 11:21
Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources.
Read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Antimalarial resistance in southeast Asia
jeudi 25 juillet 2019 • Duration 13:06
Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asia
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Trial in phage therapy for burn infections
jeudi 4 octobre 2018 • Duration 29:29
A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Pandemic influenza: 100 years
jeudi 21 juin 2018 • Duration 18:34
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
mercredi 14 février 2018 • Duration 14:11
Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
mercredi 10 janvier 2018 • Duration 12:00
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
mercredi 18 octobre 2017 • Duration 06:33
Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Related Shows Based on Content Similarities
